Limaye, S. A., Haddad, R. I., Cilli, F., Sonis, S. T., Colevas, A. D., Brennan, M. T., . . . Murphy, B. A. (2013). Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer, 119(24), 4268-4276. https://doi.org/10.1002/cncr.28365
Chicago-Zitierstil (17. Ausg.)Limaye, Sewanti Atul, Robert I. Haddad, Fiona Cilli, Stephen T. Sonis, A. Dimitrios Colevas, Michael T. Brennan, Kenneth S. Hu, und Barbara A. Murphy. "Phase 1b, Multicenter, Single Blinded, Placebo‐controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects with Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy." Cancer 119, no. 24 (2013): 4268-4276. https://doi.org/10.1002/cncr.28365.
MLA-Zitierstil (9. Ausg.)Limaye, Sewanti Atul, et al. "Phase 1b, Multicenter, Single Blinded, Placebo‐controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects with Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy." Cancer, vol. 119, no. 24, 2013, pp. 4268-4276, https://doi.org/10.1002/cncr.28365.